Skip to main content
Give
Kaper Lab
Lab SitesKaper LabJournal Articles

Journal Articles

  1. Kaper, J.B., G.S. Sayler, M.M. Baldini, and R.R. Colwell. Ambient Temperature, Primary Nonselective Enrichment for Isolation of Salmonella spp. from an Estuarine Environment. Applied and Environmental Microbiology, 1977; 33:829-835.
  2. Colwell, R.R., J. Kaper, and S.W. Joseph. Vibrio cholerae, Vibrio parahaemolyticus, and Other Vibrios: Occurrence and Distribution in Chesapeake Bay. Science, 1977; 198:394-396.
  3. Kaper, J.B., A.L. Mills, and R.R. Colwell. An Evaluation of the Accuracy and Precision of Enumeration of Aerobic Heterotrophs in Water Samples by the Spread Plate Method. Applied and Environmental Microbiology, 1978; 35:756-761.
  4. Kaper, J.B., H. Lockman, R.R. Colwell, and S.W. Joseph. Ecology, Serology and Enterotoxin Production of Vibrio choleraein Chesapeake Bay. Applied and Environmental Microbiology, 1979; 37:91-103.
  5. Naemura, L.G., S.T. Bagley, R.J. Seidler, J.B. Kaper, and R.R. Colwell. Numerical Taxonomy of Klebsiella pneumoniae Strains Isolated from Clinical and Nonclinical Sources. Current Microbioloby, 1979; 2:175-189.
  6. Kaper, J., R.J. Seidler, H. Lockman, and R.R. Colwell. A Medium for the Presumptive Identification of Aeromonas hydrophila and Enterobacteriaceae. Applied and Environmental Microbiology, 1979; 38:1023-1026.
  7. McNicol, L.A., J.B. Kaper, H.A. Lockman, E.F. Remmers, W.M. Spira, M.J. Voll, and R.R. Colwell. R-Factor Carriage in a Group F Vibrio Isolated from Bangladesh. Antimicrobial Agents and Chemotherapy, 1980; 17:512-515.
  8. McNicol, L.A., A.K. Aziz, I. Huq, J.B. Kaper, H.A. Lockman, E.F. Remmers, W.M. Spira, M.J. Voll, and R.R. Colwell. Isolation of Drug-Resistant Aeromonas hydrophila from the Aquatic Environment. Antimicrobial Agents and Chemotherapy, 1980; 17:477-483.
  9. Kaper, J.B., E.F. Remmers, and R.R. Colwell. A Medium for the Presumptive Identification of Vibrio parahaemolyticus. Journal of Food Protection, 1980; 43:936-938.
  10. Kaper, J.B., H.A. Lockman, R.R. Colwell, and S.W. Joseph. Ecology and Toxigenicity of Aeromonas hydrophila in the Chesapeake Bay. Journal of Applied Bacteriology, 1981; 50:359-377.
  11. Kaper, J.B., E.F. Remmers, H.A. Lockman, and R.R. Colwell. Distribution of Vibrio parahaemolyticus in the Chesapeake Bay. Estuaries, 1981; 4:322-327.
  12. Colwell, R.R., R.J. Seidler, J. Kaper, S.W. Joseph, S. Garges, H.A. Lockman, D. Maneval, H. Bradford, N. Roberts, E. Remmers, I. Huq, and A. Huq. Isolation of Vibrio cholerae Group 0-1 and Related Vibrios from Maryland and Louisiana Estuaries. Applied and Environmental Microbiology, 1981; 41:555-558.
  13. Kaper, J.B., S. Moseley, and S. Falkow. Molecular Characterization of Non-Toxigenic Vibrio cholerae and Related Species. Infection and Immunity, 1981; 32:661-667.
  14. Kaper, J.B., H.B. Bradford, N.C. Roberts, and S. Falkow. Molecular Epidemiology of Vibrio cholerae Resident in the U.S. Gulf Coast. Journal of Clinical Microbiology, 1982; 16:129-134.
  15. Joseph, S.W., R.R. Colwell, and J.B. Kaper. Vibrio parahaemolyticus. CRC Critical Reviews of Microbiology, 1982; 10:77-124.
  16. Roberts, N.C., R.J. Siebling, J.B. Kaper, and H.B. Bradford. Vibrios in the Louisiana Gulf Coast Environment. Microbial Ecology, 1982; 8:299-312.
  17. Shandera, W.X., B. Hafkin, D.L. Martin, J.P. Taylor, D.L. Maserang, J.G. Wells, M. Kelly, K. Ghandi, J.B. Kaper, J.V. Lee, and P.A. Blake. Persistence of Cholera in the United States. American Journal of Tropical Medicine and Hygiene, 1983; 32:812-817.
  18. Kaper, J.B., H.A. Lockman, E.F. Remmers, and R.R. Colwell. Numerical Taxonomy of Vibrio species. International Journal of Systematic Bacteriology, 1983; 33:229-255.
  19. Levine, M.M., P. Ristaino, R.B. Sack, J.B. Kaper, F. Orskov, and I. Orskov. Colonization Factor Antigens I and II and Type 1 Somatic Pili in Enterotoxigenic E. coli: Relation to Enterotoxin Type. Infection and Immunity, 1983; 39:889-897.
  20. Levine, M.M., J.B. Kaper, H. Lockman, R.E. Black, M.L. Clements, and S. Falkow. Recombinant DNA Risk Assessment Studies in Man: Efficacy of Poorly-Mobilizable Plasmids in Biologic Containment. Journal of Infectious Diseases, 1983; 148:699-709.
  21. Baldini, M.M., J.B. Kaper, M.M. Levine, D.A. Candy and H.W. Moon. Plasmid Mediated Adhesion in Enteropathogenic Escherichia coli. Journal of Pediatric Gastroenterology and Nutrition, 1983; 2:534-538.
  22. Lockman, H., and J.B. Kaper. Nucleotide Sequence Analysis of the A2 and B Subunits of Vibrio cholerae Enterotoxin. Journal of Biological Chemistry, 1983; 258:13722-13726.
  23. Levine, M.M., J.B. Kaper, R.E. Black, and M.L. Clements. New Knowledge on the Pathogenesis of Bacterial Enteric Infections as Applied to Vaccine Development. Microbiological Reviews, 1983; 47:510-550.
  24. McNicol, L.A., S.P. De, J.B. Kaper, P.A. West, and R.R. Colwell. Numerical Taxonomy of Vibrio cholerae and Related Species Isolated from Areas that are Endemic and Nonendemic for Cholera. Journal of Clinical Microbiology, 1983; 17:1102-1113.
  25. Kaper, J.B., H. Lockman, M.M. Baldini, and M.M. Levine. Recombinant Nontoxinogenic Vibrio cholerae Strains as Attenuated Cholera Vaccine Candidates. Nature, 1984; 308:655-658.
  26. O'Brien, A.D., M.E. Chen, R.K. Holmes, J. Kaper, and M.M. Levine. Environmental and Human Isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (shiga)-like cytotoxin, Lancet, 1984; 2:77-78.
  27. Kaper, J.B., R.K. Campen, R.J. Seidler, M.M. Baldini, and S. Falkow. Cloning of the Thermostable Direct or Kanagawa Phenomenon Associated Hemolysin of Vibrio parahaemolyticus. Infection and Immunity, 1984; 45:290-292.
  28. Kaper, J.B., H. Lockman, M.M. Baldini, and M.M. Levine. A Recombinant Live Oral Cholera Vaccine. Bio/Technology, 1984; 2:345-349.
  29. Lockman, H.A., J.E. Galen, and J. B. Kaper. Further analysis of the Vibrio cholerae Enterotoxin Genes: Nucleotide Sequence Analysis of the Gene Encoding the ADP-Ribosylating Subunit. Journal of Bacteriology, 1984; 159:1086-1089.
  30. Levine, M.M., R.E. Black, M.L. Clements, and J.B. Kaper. Present Status of Cholera Vaccines. Biochemical Society Transactions, 1984; 12:200-202.
  31. Datta, A.R., J.B. Kaper, and A.M. MacQuillan. Shuttle Cloning Vectors for the Marine Bacterium Vibrio parahaemolyticus. Journal of Bacteriology, 1984; 160:808-811.
  32. Hirst, T.R., J. Sanchez, J.B. Kaper, S.J.S. Hardy, and J. Holmgren. Mechanism of Toxin Secretion by Vibrio choleraeInvestigated in Strains Harboring Plasmids that Encode Heat-Labile Enterotoxins of Escherichia coli. Proceedings of the National Academy of Science, USA, 1984; 81:7752-7756.
  33. Nataro, J.P., M.M. Baldini, J.B. Kaper, R.E. Black, N. Bravo, and M.M. Levine. Detection of an Adherence Factor of Enteropathogenic Escherichia coli Using a DNA Probe. Journal of Infectious Diseases, 1985; 152:560-565."
  34. Nishibuchi, M., and J.B. Kaper. Nucleotide Sequence of Vibrio parahaemolyticus tdh (Thermostable Direct Hemolysin) Gene. Journal of Bacteriology, 1985; 162:558-564.
  35. Nataro, J.P., I.C.A. Scaletsky, J.B. Kaper, M.M. Levine, and L.R. Trabulsi. Plasmid-Mediated Factors Conferring Diffuse and Localized Adherence of Enteropathogenic Escherichia coli. Infection and Immunity, 1985; 48:378-383.
  36. Levine, M.M., J.P. Nataro, H. Karch, M.M. Baldini, J.B. Kaper, R.E. Black, M.L. Clements, and A.D. O'Brien. The Diarrheal Response of Man to Some Classical Serotype Enteropathogenic Escherichia coli is Dependent on a Plasmid Encoding an Enteroadhesiveness Factor. Journal of Infectious Disease. 1985; 152:550-559.
  37. Lanata, C.F., J.B. Kaper, M.M. Baldini, R.E. Black, and M.M. Levine. Sensitivity and Specificity of DNA Probes for the Detection of E. coli Enterotoxins Using the Stool Blot Technique. Journal of Infectious Diseases, 1985; 152:1087-1090.
  38. Nishibuchi, M., M. Ishibachi, Y. Takeda, and J.B. Kaper. Detection of the Thermostable Direct Hemolysin Gene and Related DNA Sequences in Vibrio parahaemolyticus and Other Vibrios by the DNA Colony Hybridization Test. Infection and Immunity, 1985; 49:481-486.
  39. Wright, A.C., J.G. Morris, Jr., D.R. Maneval, Jr., K. Richardson, and J.B. Kaper. Cloning of the Cytotoxin/Hemolysin of Vibrio vulnificus. Infection and Immunity, 1985; 50:922-924.
  40. Pierce, N.F., J.B. Kaper, J.J. Mekalanos, and W.C. Cray, Jr. Role of Cholera Toxin in Enteric Colonization by Vibrio cholerae 01 in Rabbits. Infection and Immunity, 1985; 50:813-816.
  41. Hedstrom, R.C., C.R. Funk, J.B. Kaper, O.R. Pavloskis, and D.R. Galloway. Cloning of a Gene Involved in Regulation of Exotoxin A Expression. Infection and Immunity, 1986; 51:37-42.
  42. Levine, M.M., G. Losonsky, D. Herrington, J.B. Kaper, C. Tacket, M. Rennels, and J.G. Morris. Pediatric Diarrhea: The Challenge of Prevention. Journal of Pediatric Infectious Diseases Supplement, 1986; 5:29-43.
  43. Lin, F.Y.C., J.G. Morris, Jr., J.B. Kaper, T. Gross, J. Michalski, C. Morrison, J.P. Libonati, and E. Israel. Persistence of Cholera in the United States: Isolation of Vibrio cholerae 01 from a Patient with Diarrhea in Maryland. Journal of Clinical Microbiology, 1986; 23:624-626.
  44. Echeverria, P., D.N. Taylor, U. Leksomboon, N.R. Blacklow, S. Pinnoi, J.P. Nataro, J. Kaper, and B. Rowe. The Identification of Enteric Pathogens in the Small and Large Intestine of Children with Diarrhea. Diagnostic Microbiology and Infectious Diseases, 1986; 4:277-284.
  45. Nishibuchi, M., W.E. Hill, G. Zon, W.L. Payne, and J.B. Kaper. Synthetic Oligodeoxyribonucleotide Probes to Detect Kanagawa Phenomenon-Positive Vibrio parahaemolyticus. Journal of Clinical Microbiology, 1986; 23:1091-1095.
  46. Baldini, M.M., J.P. Nataro, and J.B. Kaper. Localization of a Determinant for HEp-2 Adherence by Enteropathogenic Escherichia coli. Infection and Immunity, 1986; 52:334-336.
  47. Khabbaz, R.F., J.B. Kaper, M.R. Moody, S.C. Schimpff, and J.H. Tenney. Molecular Epidemiology of Group JK Corynebacteria on a Cancer Ward: Lack of Evidence for Patient to Patient Transmission. Journal of Infectious_Diseases, 1986; 154:95-99.
  48. Byun, M.O.K., J.B. Kaper, and L.O. Ingram. Construction of a New Vector for the Expression of Foreign Genes in Zymomonas mobilia. Journal of_Industrial Microbiology, 1986; 1:9-15.
  49. Kaper, J.B., J.P. Nataro, N.C. Roberts, R.J. Siebeling, and H.B. Bradford. Molecular Epidemiology of Non-01 Vibrio cholerae and V. mimicus in the U.S. Gulf Coast Region. Journal of Clinical Microbiology, 1986; 23:652-654.
  50. Wood, P.K., J.G. Morris, Jr., P.L.C. Small, O. Sethabutr, L. Trabulsi, J.B. Kaper. Comparison of DNA Probes with the Sereny Test in the Identification of Invasive Strains of Shigella and Escherichia coli. Journal of Clinical Microbiology, 1986; 24:498-500.
  51. Thompson, M.R., R.L. Jordan, M.A. Luttrell, H. Brandwein, J.B. Kaper, M.M. Levine, and R.A. Giannella. A Blinded, Two Laboratory Comparative Analysis of E. coli STa Production Using Monoclonal Antibody ELISA, Radioimmunoassay, Suckling Mouse Assay, and Gene Probe Analysis. Journal of Clinical Microbiology, 1986; 24:753-758.
  52. Richardson, K., J. Michalski, and J.B. Kaper. Hemolysin Production and Cloning of Two Hemolysin Determinants from Classical Vibrio cholerae. Infection and Immunity, 1986; 54:415-420.
  53. Honda, T., M. Nishibuchi, T. Miwatani, and J.B. Kaper. Demonstration of a Plasmid-Borne Gene Expressing a Thermostable Direct Hemolysin in Vibrio cholerae Non-01 Strains. Applied and Environmental Microbiology, 1986; 52:1218-1220.
  54. Knutton, S., M.M. Baldini, J.B. Kaper, and A.S. McNeish. Role of Plasmid-Encoded Adherence Factors in Adhesion of Enteropathogenic Escherichia coli to HEp-2 cells. Infection and Immunity, 1987; 55:78-85.
  55. Levine, M.M., Y. Jian-guo, J.B. Kaper, H. Lior, V. Prado, B. Tall, J. Nataro, H. Karch, I.K. Wachsmuth, and C. Roggs. A Sensitive and Specific DNA Probe to Identify Enterohemorrhagic Escherichia coli of 0157:H7 and Other Serotypes that Cause Hemorrhagic Colitis and Hemolytic Uremic Syndrome. Journal of Infectious Diseases, 1987; 156:175-182.
  56. Pierce, N.F., J.B. Kaper, J.J. Mekalanos, W.C. Cray, Jr., K. Richardson. Determinants of the Immunogenicity of Live Virulent and Mutant Vibrio cholerae 01 in Rabbit Intestine. Infection and Immunity, 1987; 55:477-481.
  57. Nataro, J.P., K.O. Maher, P. Mackie, and J.B. Kaper. Characterization of Plasmids Encoding the Adherence Factor of Enteropathogenic Escherichia coli. Infection and Immunity, 1987; 55:2370-2377.
  58. Karch, H., J. Heesemann, R. Laufs, H.P. Kroll, J.B. Kaper, and M.M. Levine. Serological Response to Type 1-Like Somatic Fimbriae in Diarrheal Infection Due to Classical Enteropathogenic Escherichia coli. Microbial Pathogenesis, 1987; 2:425-434.
  59. Nataro, J.P., J.B. Kaper, R.Robins-Browne, V. Prado, P. Vial, and M.M. Levine. Patterns of Adherence of Diarrheagenic Escherichia coli to HEp-2 Cells. Pediatric Infectious Disease, 1987; 6:829-831.
  60. Echeverria, P., D.N. Taylor, A. Donohue-Rolfe, K. Supawat, O. Ratchtrachenchai, J. Kaper, and G.T. Keusch. HeLa Cell Adherence and Cytotoxin Production by Enteropathogenic Escherichia coli Isolated from Infants with Diarrhea in Thailand. Journal of Clinical Microbiology, 1987; 25:1519-1523.
  61. Chatkaeomorakot, A., P. Echeverria, D.N. Taylor, K.A. Bettelheim, N. R. Blacklow, O. Sethabutr, J. Seriwatana, and J. Kaper. HeLa Cell-Adherent Escherichia coli in Children with Diarrhea in Thailand. Journal of Infectious Diseases, 1987; 156:669-672.
  62. Levine, M.M., J.B. Kaper, D. Herrington, G. Losonsky, J.G. Morris, M.L. Clements, R.E. Black, B. Tall, and R. Hall. Volunteer Studies of Deletion Mutants of Vibrio cholerae Prepared by Recombinant Techniques. Infection and Immunity, 1988; 56:161-167.
  63. Pierce, N.F., W.C. Cray, Jr., J.B. Kaper, and J.J. Mekalanos. Determinants of Immunogenicity and Mechanisms of Protection by Virulent and Mutant Vibrio cholerae 01 in Rabbits. Infection and Immunity, 1988; 56:142-148.
  64. Kaper, J.B., and M.M. Levine. Progress Towards a Vaccine Against Enterotoxigenic Escherichia coli. Vaccines, 1988; 6:197-199.
  65. Vimr, E.R., L. Lawrisuk, J. Galen, and J.B. Kaper. Cloning and Expression of the Vibrio cholerae Neuraminidase Gene nanH in Escherichia coli. Journal of Bacteriology, 1988; 170:1495-1504.
  66. Levine, M.M., V. Prado, R. Robins-Browne, H. Lior, J.B. Kaper, S.L. Moseley, K. Gicquelais, J.P. Nataro, P.A. Vial, B. Tall. DNA Probes and HEp-2 Cell Adherence Assay to Detect Diarrheagenic Escherichia coli. Journal of Infectious Diseases, 1988; 158:224-228.
  67. Vial, P.A., R. Robins-Browne, H. Lior, V. Prado, J.B. Kaper, J.P. Nataro, D. Maneval, A. Elsayed, and M.M. Levine. Characterization of Enteroadherent-Aggregative Escherichia coli: A Putative Agent of Diarrheal Disease. Journal of Infectious Diseases, 1988; 158:70-79.
  68. Hall, R.H., P.A. Vial, J.B. Kaper, J.J. Mekalanos, and M.M. Levine. Morphological Studies on Fimbriae Expressed by Vibrio cholerae 01. Microbial Pathogenesis, 1988; 4:257-265.
  69. Levine, M.M., J.B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C.O. Tacket, B. Tall, and S. Cryz. Safety, Immunogenicity, and Efficacy of Recombinant Live Oral Cholera Vaccines, CVD103 and CVD103-HgR. Lancet, 1988; ii:467-470.
  70. Nair, G.B., Y. Oku, Y. Takeda, A. Ghosh, R.K. Ghosh, S. Chattopadyay, S.C. Pal, J.B. Kaper, and T. Takeda. Toxin Profiles of Vibrio cholerae Non-O1 from Environmental Sources in Calcutta, India. Applied and Environmental Microbiology, 1988; 54:3180-3182.
  71. Levine, M.M., J.B. Kaper, D. Herrington, G. Losonsky, C. Tacket and B. Tall. The Current Status of Cholera Vaccine Development and Experience with Cholera Vaccines Trials in Volunteers. Southeast Asian J Trop Med Pub Hlth, 1988; 19:401-415.
  72. Kaper, J.B., and C.O. Tacket. Application of Biotechnology to Vaccine Development. Developments in Industrial Microbiology (Journal of Industrial Microbiology, Suppl. No. 3), 1988; 29:109-118.
  73. Richardson, K., J.B. Kaper, and M.M. Levine. Human Immune Response to Vibrio cholerae Whole Cells and Isolated Outer Membrane Antigens. Infection and Immunity, 1989; 57:495-501.
  74. Bhan, M.K., P. Raj, M.M. Levine, J.B. Kaper, N. Bhandari, R. Srivastava, R. Kumar, and S. Sazawal. Enteroaggregative Escherichia coli Associated with Persistent Diarrhea in a Cohort of Rural Children in India. Journal of Infectious Disease, 1989; 159:1061-1064.
  75. Miliotis, M.D., J.E. Galen, J.B. Kaper, and J.G. Morris, Jr. Development and Testing of a Synthetic Oligonucleotide Probe for the Detection of Pathogenic Yersinia Strains. Journal of Clinical Microbioloby, 1989; 27:1667-1670.
  76. Kaper, J.B. Vibrio cholerae Vaccines. Reviews of Infectious Diseases, 1989;11 (Suppl. 3):S568-S573.
  77. Migasena, S., P. Pitisuttitham, B. Prayurahong, P. Suntharasamai, W. Supanaranond, V. Desakorn, U. Vongsthongsril, B. Tall, J. Ketley, G. Losonsky, S. Cryz, J.B. Kaper, M.M. Levine. Preliminary Assessment of the Safety and Immunogenicity of Live Oral Cholera Vaccine Strain CVD 103-HgR in Healthy Thai Adults. Infection and Immunity, 1989; 57:3261-3264.
  78. Roggentin, P., B. Rothe, J.B. Kaper, J. Galen, L. Lawrisuk, E.R. Vimr and R. Schauer. Conserved Sequences in Bacterial and Viral Sialidases. Glycoconjugate, 1989; 6:349-353.
  79. Bhan, M.K., N. Bhandari, S. Sazawal, J. Clemens, P. Raj, M.M. Levine and J.B. Kaper. Descriptive Epidemiology of Persistent Diarrhoea Among Young Children in Rural Northern India. Bulletin of the World Health Organization, 1989; 67:281-288.
  80. Nishibuchi, M. and J.B. Kaper. Duplication and Variation of the Thermostable Direct Hemolysin (tdh) Gene in Vibrio parahaemolyticus. Molecular Microbiology. 1990; 4:87-99.
  81. Nishibuchi, M., V. Khaeomanee-iam, T. Honda, J.B. Kaper and T. Miwatani. Comparative Analysis of the Hemolysin Genes of Vibrio cholerae non-01, V. mimicus, and V. hollisae that are Similar to the tdh gene of V. parahaemolyticus. FEMS Microbiology Letter. 1990; 67:251-256.
  82. Ketley, J.M, J.B. Kaper, D.A. Herrington, G. Losonsky and M.M. Levine. Diminished Immunogenicity of a Recombination-Deficient Derivative of Vibrio cholerae vaccine strain CVD103. Infection and Immunity, 1990; 58:1481-1484.
  83. Marcus, H., J.M. Ketley, J.B. Kaper, and R.K. Holmes. Effects of DNase Production, Plasmid Size, and Restriction Barriers on Transformation of Vibrio cholerae by Electroporation and Osmotic Shock. FEMS Microbiology Letters. 1990; 68:149-154.
  84. Baudry, B., S.J. Savarino, P. Vial, J.B. Kaper, M.M. Levine. A Sensitive and Specific DNA Probe to Identify Enteroaggregative Escherichia coli, a Recently-Discovered Diarrheal Pathogen. Journal of Infectious Diseases. 1990; 161:1249-1251.
  85. Richardson, K., L. Nixon, P. Mostow, J.B. Kaper, and J. Michalski. Transposon-Induced Non-motile Mutants of Vibrio cholerae. Journal of General Microbiology. 1990; 136:717-725.
  86. Donnenberg, M.S., S.B. Calderwood, A. Donohue-Rolfe, G.T. Keusch, J.B. Kaper. Construction and Analysis of TnphoA Mutants of Enteropathogenic Escherichia coli Unable to Invade HEp-2 cells. Infection and Immunity, 1990; 58:1565-1571.
  87. Cryz, Jr., S.J., M.M. Levine, J.B. Kaper, E. Furer, and B. Althaus. Randomized Double-blind Placebo-controlled Trial to Evaluate the Safety and Immunogenicity of the Live Oral Cholera Vaccine Strain CVD 103-HgR in Swiss Adults. Vaccine, 1990; 8:577-580.
  88. Yamamoto, K., A.C. Wright, J.B. Kaper, and J.G. Morris, Jr. The Cytolysin Gene of Vibrio vulnificus: Sequence and Relationship to Vibrio cholerae El Tor Cytolysin. Infection and Immunity, 1990; 58:2706-2709.
  89. Jerse, A.E., J. Yu, B.D. Tall, and J.B. Kaper. A Genetic Locus of Enteropathogenic Escherichia coli Necessary for Production of Attaching and Effacing Lesions on Tissue Culture Cells. Proceedings of the National Academic of Sciences, USA, 1990; 87:7839-7843.
  90. Caron, J., D.R. Maneval, J.B. Kaper, and J.R. Scott. Association of rns Homologs with CFA Antigen in Clinical Escherichia coli Isolates. Infection and Immunity, 1990; 58:3442-3444.
  91. Gicquelais, K.G., M.M. Baldini, J. Martinez, L. Maggi, W.C. Martin, V. Prado, J. B. Kaper, and M.M. Levine. Practical and Economical Method for Using Biotinylated DNA Probes with Bacterial Colony Blots to Identify Diarrhea- Causing Escherichia coli. Journal Clinical Microbiology, 1990; 28:2485-2490.
  92. Kaper, J.B. and M.M. Levine. Recombinant Attenuated Vibrio cholerae Strains used as Live Oral Vaccines. Research in Microbiology, 1990; 141:901-906.
  93. Jerse, A.E., W.C. Martin, J.E. Galen, and J.B. Kaper. An Oligonucleotide Probe for the Detection of the EPEC Adherence Factor EAF of Localized Adherent Enteropathogenic Escherichia coli. Journal of Clinical Microbiology. 1990; 28:2842-2844.
  94. Giron, J.A., T. Jones, F. Millan-Velasco, E. Munoz-Castro, J. Fry, G. Frankel, S.L. Moseley, B. Baudry, J.B. Kaper, G.K. Schoolnik, and L.W. Riley. Diffuse-adhering Escherichia coli (DAEC) as a Putative Cause of Diarrhea in Mayan Children in Mexico. Journal of Infectious Diseases. 1991; 163:507-513.
  95. Fasano, A., B. Baudry-Maurelli, D.W. Pumplin, S.S. Wasserman, B.D. Tall, J.M. Ketley, and J.B. Kaper. Vibrio cholerae Produces a Second Enterotoxin Which Affects Intestinal Tight Junctions. Proceedings of the National Academy of Science, USA. 1991; 88:5242-5246.
  96. Francis C. L., A.E. Jerse, J.B. Kaper, and S. Falkow. Characterization of Interactions of Enteropathogenic Escherichia coli 0127:H6 with Mammalian Cells in vitro. Journal of Infectious Diseases. 1991; 164:693-703.
  97. Lind, C.D., R.H. Davis, R.L. Guerrant, J.B. Kaper, and J.R. Mathias. Effects of Vibrio cholerae Recombinant Strains on Rabbit Ileum in vivo. Enterotoxin Production and Myoelectric Activity. Gastroenterology. 1991; 101:319-324.
  98. Nishibuchi, M., K. Kumagai, Y. Takeda, and J.B. Kaper. Contribution of the tdh1 gene of Kanagawa Phenomenon-positive Vibrio parahaemolyticus to Production of Extracellular Thermostable Direct Hemolysin. Microb. Pathogenesis. 1991; 6:453-460.
  99. Jerse, A.E., K.G. Gicquelais and J.B. Kaper, Plasmid and Chromosomal Elements Involved in the Pathogenesis of Attaching and Effacing Escherichia coli. Infection and Immunity. 1991; 59:3869-3875.
  100. Jerse, A.E., and J.B. Kaper. The eae gene of Enteropathogenic Escherichia coli Encodes a 94 kDa Membrane Protein, the Expression of Which is Influenced by the EAF Plasmid. Infection and Immunity. 1991. 59:4302-4309.
  101. Donnenberg, M.S., and J.B. Kaper. Construction of an eae Deletion Mutant of Enteropathogenic Escherichia coli by Using a Positive-Selection Suicide Vector. Infection and Immunity. 1991; 59:4310-4317.
  102. Galen, J.E., J.M. Ketley, A. Fasano, S.H. Richardson, S.S. Wasserman and J.B.Kaper. Role of Vibrio cholerae Neuraminidase in the Function of Cholera Toxin. Infection and Immunity. 1992; 60:406-415.
  103. Baudry, B., A. Fasano, J. Ketley, and J.B. Kaper. Cloning of a Gene (zot) Encoding a New toxin Produced by Vibrio cholerae. Infection and Immunity. 1992; 60-428-434.
  104. Yu, J. and J.B. Kaper. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli 0157:H7. Molecular Microbiology. 1992; 6:411-417.
  105. Barrett, T.J., J.B. Kaper, A.E. Jerse, and I.K. Wachsmuth. Virulence Factors in Shiga-like Toxin Producing Escherichia coli Isolated from Humans and Cattle. Journal of Infectious Diseases. 1992; 165:979-980.
  106. Finlay, B.B., I. Rosenshine, M.S. Donnenberg, and J.B. Kaper. Cytoskeletal Composition of Attaching and Effacing Lesions Associated with Enteropathogenic Escherichia coli Adherence to HeLa Cells. Infection and Immunity. 1992; 60:2541-2547.
  107. Donnenberg, M.S., and J.B. Kaper. Mini-Review: Enteropathogenic Escherichia coli. Infection and Immunity. 1992; 60:3953-3961
  108. Nishibuchi, M., A. Fasano, R.G. Russell, and J.B. Kaper. "Enterotoxigencity of Vibrio parahaemolyticus with and without Genes Encoding Thermostable direct Hemolysin." Infection and Immunity. 1992; 60:3539-3545.
  109. Cryz, S.J., M.M. Levine, G. Losonsky, J.B. Kaper and B. Althaus. Safety and Immunogenicity of a Booster Dose of Vibrio cholerae CVD 103-HgR Live Oral Cholera Vaccine in Swiss Adults. Infection and Immunity. 1992; 60:3916-3917.
  110. Su-Arehawaratana, P., P. Singharaj, D.N. Taylor, C. Hoge, A. Trofa, K. Kuvanont, S. Migasena, P. Pitisuttiham, Y.L. Lim, G. Losonsky, J.B. Kaper, S.S. Wasserman, S. Cryz, P. Echeverria, and M.M. Levine. Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral cholera Vaccine in Soldiers and Civilians in Thailand. Journal of Infectious Diseases. 1992; 165:1042-1048.
  111. Rosenshine, I., M.S. Donnenberg, J.B. Kaper, and B.B. Finlay. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO Journal 1992; 11:3551-3560.
  112. Tacket, C.O., G. Losonsky, J.B. Kaper, and M.M. Levine. Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD 103-HgR. Journal of Infectious Diseases, 1992; 166:837-841.
  113. Suharyono, C. Simanjuntak, N. Witham, N. Punjabi, D.G. Heppner, G. Losonsky, H. Totosudirjo, A.R. Rifai, J. Clemens, D. Burr, S.S. Wasserman, J.B. Kaper, K. Sorenson, S. Cryz, and M.M. Levine. Safety and immunogenicity of a single-dose live oral cholera vaccine CVD 103-HgR in 5-9 year-old Indonesian children. Lancet, 1992, 340:689-694.
  114. Donnenberg, M.S., J.A. Giron, J.P. Nataro and J.B. Kaper. A Plasmid-encoded Type IV Fimbrial Gene of Enteropathogenic Escherichia coli Associated with Localized Adherence. Molecular Microbiology 1992, 6:3427-3437.
  115. Kaper, J.B., and B.S. Srivastava. Genetics of Cholera Toxin. Indian Journal of Medical Research 1992, (A)95:163-167.
  116. Levine, M.M., and J.B. Kaper. Live Oral Vaccines Against Cholera: An Update. Vaccine 1993, 11:207-212.
  117. Losonsky, G.A., C.O. Tacket, S.S. Wasserman, J.B. Kaper, and M.M. Levine. Secondary Vibrio cholerae-Specific Cellular Antibody Responses Following Wild-Type Homologous Challenge in People Vaccinated with CVD 103-HgR Live Oral Cholera Vaccine: Changes with Time and Lack of Correlation with Protection. Infection and Immunity. 1993, 61:729-733.
  118. Trucksis M., J.E. Galen, J. Michalski, A. Fasano, and J.B. Kaper. Accessory Cholera Enterotoxin (Ace), the Third Member of a Vibrio cholerae Virulence Cassette. Proceedings of the National Academy of Sciences USA. 1993, 90:5267-5271.
  119. Jacob, A., V.B. Sinha, M.K. Sahib, R. Srivastava, J.B. Kaper, B.S. Srivastava. Identification of a 33 kDa Antigen Associated with an Adhesive and Colonizing Strain of Vibrio cholerae El tor and its Role in Protection. Vaccine. 1993,11:376-382.
  120. Sinha, V.B., A. Jacob, R. Srivastava, J.B. Kaper, and B.S. Srivastava. Identification of the Flagellar Antigens of Vibrio cholerae El Tor and Their Role in Protection. Vaccine. 1993, 11:372-375.
  121. Johnson, J.A., J.G. Morris, Jr., and J.B. Kaper. Gene Encoding Zonula Occludens Toxin (zot) Does not Occur Independently from Cholera Enterotoxin Genes (ctx) in Vibrio cholerae. Journal of Clinical Microbiology. 1993, 31:732-733.
  122. Donnenberg, M.S., S. Tzipori, M.L. McKee, A.D. O'Brien, J. Alroy, and J.B. Kaper. The Role of the eae Gene of Enterohemorrhagic Escherichia coli in Intimate Attachment in Vitro and in a Porcine Model. Journal of Clinical Investigation. 1993, 92:1418-1424.
  123. Donnenberg, M.S., C.O. Tacket, S.P. James, G. Losonsky, J.P. Nataro, S.S. Wasserman, J.B. Kaper, and M.M. Levine. The Role of the eaeA Gene in Experimental Enteropathogenic Escherichia coli Infection. Journal of Clinical Investigation. 1993, 92:1412-1417.
  124. Donnenberg, M.S., J. Yu, and J.B. Kaper. A Second Chromosomal Gene Necessary for Intimate Attachment of Enteropathogenic Escherichia coli to Epithelial Cells. Journal of Bacteriology. 1993, 175:4670-4680.
  125. Ketley, J.M., J. Michalski, J. Galen, M.M. Levine, and J.B. Kaper. Construction of Genetically-Marked Vibrio cholerae O1 Vaccine Strains. FEMS Microbiology Letter. 1993, 111:15-22.
  126. Michalski, J., J.E. Galen, A. Fasano, and J.B. Kaper. CVD110: An Attenuated Vibrio cholerae 01 El Tor Live Oral Vaccine Strain. Infection and Immunity. 1993, 61:4462-4468.
  127. Canil, C., I. Rosenshine, S. Ruschkowski, M.S. Donnenberg, J.B. Kaper, and B.B. Finlay. Enteropathogenic Escherichia coli Decreases the Transepithelial Electrical Resistance of Polarized Epithelial Monolayers. Infection and Immunity. 1993, 61:2755-2762.
  128. Girón, J.A., M.S. Donnenberg, W.C. Martin, K.G. Jarvis, and J.B. Kaper. Distribution of the Bundle-Forming Pilus Structural Gene (bfpA) among Enteropathogenic Escherichia coli. Journal of Infectious Diseases.1993, 168:1037-1041.
  129. Gotuzzo E, Butron B, Seas C, Penny M, Ruiz R, Losonsky G, Lanata CR, Wasserman SS, Salazar E, Kaper JB, Cryz S, Levine MM. Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine, CVD 103-HgR in Peruvian adults of high and low socioeconomic level. Infection and Immunity, 1993, 61:3994-3997.
  130. Lagos R, Avendaño A, Horwitz I, Prado V, Ferreccio C, Sotomayor V, Losonsky G, Wasserman SS, Cryz S, Kaper JB, Levine MM. Tolerance and immunogenicity of an oral dose of CVD 103-HgR: a double blind study in Chilean adults. Revista Médica de Chile, 1993, 121:857-863.
  131. Simanjuntak, C.H., P. O'Hanley, N.H. Punjabi, F. Noriega, G. Pazzaglia, P. Dykstra, B. Kay, Suharyono, A. Budiarso, A.R. Rifai, S.S. Wasserman, G. Losonsky, J. Kaper, S. Cryz, and M.M. Levine. Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children. Journal of Infectious Diseases. 1993, 168:1169-1176.
  132. Tacket, C.O., G. Losonsky, J.P. Nataro, S. J. Cryz, R. Edelman, A. Fasano, J. Michalski, J.B. Kaper, and M.M. Levine. Safety and Immunogenicity of Live Oral Cholera Vaccine Candidate CVD 110, a ?ctxA, ?zot, ?ace Derivative of El Tor Ogawa Vibrio cholerae. Journal of Infectious Diseases. 1993, 168:1536-1540.
  133. Lagos, R., A. Avendaño, I. Horwitz, V. Prado, C. Ferreccio, V. Sotomayor, G. Losonsky, S.S. Wasserman, S. Cryz, J.B. Kaper, and M.M. Levine. Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: A double blind study in Chilean adults. Rev. Med. Chile. 1993, 121:856-863.
  134. Scott, D.A. and J.B. Kaper. Cloning and Sequencing of Genes Encoding Cytolethal Distending Toxin of Escherichia coli. Infection and Immunity. 1994, 62:244-251.
  135. Kaper, J.B., J. Michalski, J.M. Ketley, and M.M. Levine. Potential for Reacquisition of Cholera Enterotoxin Genes by Attenuated Vibrio cholerae Vaccine Strain CVD 103-HgR. Infection and Immunity. 1994, 62:1480-1483.
  136. Kumar, K.K., R. Srivastava, V.B. Sinha, J.B. Kaper, and B.S. Srivastava. Effect of recA Mutation on Vibrio cholerae Adherence and Colonization. Microbiology (Journal of General Microbiology) . 1994, 140:1217-1222.
  137. Girón, J.A., M.M. Levine, and J.B. Kaper. Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli. Molecular Microbiology. 1994, 12:71-82.
  138. Faruque, S.M., L. Comstock, J.B. Kaper, and M. J. Albert. Prevalence of zonula occludens toxin (zot) Gene Among Clinical Isolates of Vibrio cholerae O1 from Bangladesh and Africa. J. Diarrhoeal Disease. Research., 1994, 12:222-224.
  139. Kaper, J.B., J.G. Morris, Jr., and M.M. Levine. Cholera. Clinical Microbiology Reviews. 1995, 8:48-86. 
  140. Comstock, L.E., D. Maneval, Jr., P. Panigrahi, A. Joseph, M.M. Levine, J.B. Kaper, J.G. Morris, Jr., and J.A. Johnson. Capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infection and Immunity. 1995, 63:317-323.
  141. Lagos, R., A. Avendano, V. Prado, I. Horwitz, S. Wasserman, G. Losonsky, S. Cryz Jr, J.B. Kaper, and M.M. Levine. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titres in persons of blood group O. Infection and Immunity 1995, 63:707-709.
  142. Gomez-Duarte, O.G. and J.B. Kaper. A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infection and Immunity, 1995, 63:1767-1776.
  143. McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. A genetic locus of enterotcyte effacement conserved among diverse enterobacterial pathogens. Proceedings of the National Academy of Sciences USA, 1995, 92:1664-1668.
  144. Nishibuchi, M. and J.B. Kaper. Thermostable direct hemolysin gene of Vibrio parahaemolyticus: a virulence gene acquired by a marine bacterium. Infection and Immunity, 1995, 63:2093-2099.
  145. Raimondi, F., J.P.Y. Kao, J.B. Kaper, S. Guandalini, and A. Fasano. Calcium-dependent intestinal chloride secretion induced by the thermostable direct hemolysin of Vibrio parahaemolyticus in rabbit ileum. Gastroenterology, 1995, 109:381-386.
  146. Fasano, A., C. Fiorentini, G. Donelli, J.B. Kaper, K. Margaretten, X. Ding, S. Guandalini, L. Comstock, and S.E. Goldblum. Zonula occludens toxin (ZOT) modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. Journal of Clinical Investigation, 1995, 96:710-720.
  147. Jarvis, K. G., J. A. Girón, A. E. Jerse, T. K. McDaniel, M. S. Donnenberg, and J. B. Kaper. Enteropathogenic Escherichia coli contains a specialized secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proceedings of the National Academy Science USA, 1995, 92:7996-8000.
  148. Gabastou, J.M., S. Kernéis, M.F. Bernet-Camard, A. Barbat, M.H. Coconnier, J.B. Kaper, and A.L. Servin. Two stages of enteropathogenic Escherichia coli intestinal pathogenicity are up- and down-regulated by the epithelial cell differentiation. Differentiation, 1995,59:127-134.
  149. Girón, J.A., J-G Xu, C. R. Gonzalez, D. Hone, J.B. Kaper, and M.M. Levine. Simultaneous and constitutive expression of CFA/I and CS3 colonization factors of enterotoxigenic Escherichia coli by ?aroC, ?aroD Salmonella typhi vaccine strain CVD 908. Vaccine, 1995, 13:939-946.
  150. Tzipori, S., F. Gunzer, M.S. Donnenberg, L. DeMontigny, J.B. Kaper, and A. Donogue-Rolfe. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infection and Immunity, 1995, 63:3621-3627.
  151. Tacket, C.O., G. Losonsky, J.P. Nataro, L. Comstock, J. Michalski, R. Edelman, J.B. Kaper and M.M. Levine. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: Safety and efficacy against experimental challenge. Journal of Infectious Disease, 1995, 172:883-886.
  152. Girón, J.A., G.I. Viboud, V. Sperandio, A.G. Gómez-Duarte, D.R. Maneval, M.J. Albert, M.M. Levine and J.B. Kaper. Prevalence and association of the longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin types, and serotypes of enterotoxigenic Escherichia coli. Infection and Immunity, 1995, 63:4195-4198.
  153. Sperandio, V., J.A. Girón, W.D. Silveira and J.B. Kaper. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae.Infection and Immunity, 1995, 63:4433-4438.
  154. Girón, J.A., F. Qadri, T. Azim, K.J. Jarvis, J.B.Kaper and M.J. Albert. Monoclonal antibodies specific for the bundle-forming pilus of the Enteropathogenic Escherichia coli. Infection and Immunity, 1995, 63:4949-4952.
  155. Smith, C.J., J.B. Kaper, D.R. Mack. Intestinal mucin inhibits adhesion of human enteropathogenic Escherichia coli to Hep-2 Cells. Journal of Pediatric Gastroenterology and Nutrition, 1995, 21:269-276.
  156. Levine, M.M. and J.B. Kaper. Live oral cholera vaccine: from principle to product. Bull Inst Pasteur, 1995, 93:243-353.
  157. Sears, C.L. and J.B. Kaper. Enteric bacterial toxins: Mechanisms of action and linkage to intestinal secretion. Microbiological Reviews, 1996, 60:167-215.
  158. Comstock, J.E., J.A. Johnson, J.M. Michalski, J.G. Morris, Jr. and J.B. Kaper. Cloning and sequence of a region encoding surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Molecular Microbiology, 1996, 19:815-826.
  159. Acheson, D.W.K., M.M. Levine, J.B. Kaper, and G.T. Keusch. Protective immunity to shiga-like toxin-I following oral immunization with shiga-like toxin-I B subunit producing V. cholerae CVD 103-HgR. Infection and Immunity, 1996, 64:355-357.
  160. Albert, M.J., S.M. Faruque, A.S.G. Faruque, K.A. Bettelheim, P.K.B. Neogi, N.A. Bhuiyan, and J.B. Kaper. Controlled study of cytolethal distending toxin-producing Escherichia coli infections in Bangladeshi children. Journal of Clinical Microbiology, 1996, 34:717-719.
  161. Silva, T.M.J., M.A. Schleupner, C.O. Tacket, T.S. Steiner, J.B. Kaper, R. Edelman, R.L. Guerrant. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and 0139 Vibrio cholerae. Infection and Immunity, 1996, 64:2362-2364.
  162. Jarvis, K.G. and J.B. Kaper. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infection and Immunity, 1996, 64:4826-4829.
  163. Sperandio, V., C. Bailey, J.A. Giron, W.D. Silveira, A. L. Vettore, J. B. Kaper. Cloning and characterization of the gene encoding the OmpU outer membrane protein of Vibrio cholerae. Infection and Immunity, 1996, 64:5406-5409.
  164. Sanger, J. M., R. Chang, F. Ashton, J. B. Kaper, and J. W. Sanger. Novel form of actin-based motility transports bacteria on the surfaces of infected cells. Cell Motility and the Cytoskeleton. 1996, 34:279-287.
  165. Kaper, J. B., T. K. McDaniel, and K. G. Jarvis. Molecular genetics of enteropathogenic Escherichia coli. Rev. Microbiol. Sào Paulo, 1996, 27 (Suppl. 1):82-88.
  166. Kaper, J. B. Defining EPEC. Rev. Microbiol. Sào Paulo, 1996, 27(Suppl.1):130-133.
  167. Rabinowitz, R. R., L-C. Lai, K. Jarvis, T. K. McDaniel, J.B. Kaper, K. D. Stone, M. S. Donnenberg. Attaching and effacing of host cells by enteropathogenic Escherichia coli in the absence of detectable tyrosine kinase mediated signal transduction. Microbial Pathogenesis, 1996, 21:157-171.
  168. Girón, J.A., O.G. Gomez-Duarte, K. G. Jarvis, and J.B. Kaper. Longus pilus of enterotoxigenic Escherichia coli and its relatedness to other type-4 pili - a minireview. Gene, 1997, 192:39-43.
  169. McDaniel, T.K. and J.B. Kaper. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Molecular Microbiology, 1997, 23:399-407.
  170. Franco, A. A., L.M. Mundy, M. Trucksis, S. Wu, J.B. Kaper, and C. L. Sears. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infection and Immunity. 1997. 65:1007-1013.
  171. Hedberg, C.W., S.J. Savarino, J.M. Besser-Wiek, C.J. Paulus, V.M. Thelen, L.J. Myers, D.N. Cameron, T.J. Barrett, J.B. Kaper, M.T. Osterholm, and the Investigation Team. An outbreak of foodborne illness caused by Escherichia coli O39:NM: A diarrheagenic E. coli that does not fit into the existing scheme for classifying diarrheagenic E. coli. Journal of Infectious Diseases. 1997, 176:1625-1628.
  172. Donnenberg, M.S., J.B. Kaper, B.B. Finlay. Enteropathogenic Escherichia coli interactions with host cells. Trends in Microbiology. 1997, 6:109-114.
  173. Tacket, C.O., K.L. Kotloff, G. Losonsky, J.P. Nataro, J. Michalski, J.B. Kaper, R. Edelman, M.M. Levine. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. American Journal of Tropical Medicine and Hygiene. 1997. 56:533-537.
  174. Fiore, A.E., M. M. Michalski, R. G. Russell, C. L. Sears, and J.B. Kaper. Cloning, characterization and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae. Infection and Immunity. 1997, 65:3112-3117.
  175. Losonsky, G. A., Y. Lim, P. Motamedi, L. E. Comstock, J. A. Johnson, J. G. Morris, Jr., C. O. Tacket, J. B. Kaper, and M. M. Levine. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clinical and Diagnostic Laboratory Immunology. 1997, 4:264-269.
  176. Elliott, S. J. and J. B. Kaper. Role of type 1 fimbriae in EPEC infections. Microbial Pathogenesis, 1997, 23:113-118.
  177. Taylor, D.N., Tacket, C.O., Losonsky, G., Castro, O., Meza, R., Nataro, J.P., Kaper, J.B., Wasserman, S.S., Edelman, R., Levine, M.M., Cryz, S.J. Evaluation of a Bivalent (CVD 103-HgR/CVD 111) Live Oral Cholera Vaccine in U.S. and Peruvian Adults. Infection and Immunity 1997, 65:3852-3856.
  178. Wieler, L. H., T. K. McDaniel, T. S. Whittam, J. B. Kaper. Insertion site of the locus of enterocyte effacement in enteropathogenic and enterohemorrhagic E. coli differs in relation to the strains' clonal phylogeny. FEMS Microbiology Letters 1997, 156:49-53.
  179. Trucksis, M., T. L. Conn, A. Fasano, and J. B. Kaper. Production of Vibrio cholerae Accessory Cholera Enterotoxin (ACE) in the yeast Pschia pastoris. Infection and Immunity. 1997, 65:4984-4988.
  180. Nataro, J. P. and J. B. Kaper. Diarrheagenic Escherichia coli. Clinical Microbiology Reviews 1998, 11:142-201.
  181. Kaper, J. B. Enterohemorrhagic Escherichia coli. Current Opinion in Microbiology 1998, 1:103-108.
  182. Tacket, C. O., R. K. Taylor, G. Losonsky, Y. Lim, J. P. Nataro, J. B. Kaper, and M. M. Levine. Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infection and Immunity 1998, 66:692-695.
  183. Karaolis, D. K. R., J. A. Johnson, C. C. Bailey, E. C. Boedeker, J. B. Kaper, P. R. Reeves. A Vibrio cholerae pathogenicity island (VPI) associated with epidemic and pandemic strains. Proceedings of the National Academy of Sciences, USA. 1998, 95:3134-3139.
  184. Wainwright, L. A. and J. B. Kaper. EspB and EspD require a specific chaperone for proper secretion from enteropathogenic Eschericia coli. Molecular Microbiology, 1998, 27:1247-1260.
  185. Crawford, J.A., J. B. Kaper, and V. J. DiRita. Analysis of ToxR-dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae. Molecular Microbiology, 1998, 29:235-246.
  186. Elliott, S.J., L.A. Wainwright, T. K. McDaniel, K. G. Jarvis, Y.Deng, L-C. Lai, B.P.McNamara, M.S. Donnenberg, and J. B. Kaper. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic E. coli E2348/69. Molecular Microbiology, 1998, 28:1-4.
  187. Kaper, J. B. EPEC delivers the goods. Trends in Microbiology 1998 6:169-172.
  188. Hicks, S., G. Frankel, J. B. Kaper, G. Dougan, and A. D. Phillips. Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestine in vitro. Infection and Immunity 1998 66:1570-1578.
  189. Sperandio, V., J. B. Kaper, M. R. Bortolini, B. C. Neves, R. Keller, and L. R. Trabulsi. Characterization of the Locus of Enterocyte Effacement (LEE) in different enteropathogenic Escherichia coli (EPEC) and Shiga toxin-producing E. coli (STEC) serotypes. FEMS Microbiology Letters 1998 164:133-139.
  190. McGrath,D., D. W. K. Acheson, J. B. Kaper, and G. T. Keusch. Protective immunity to Shiga toxin (Stx1) 1 following oral immunization with Stx 1 B-subunit producing V. cholerae CVD 111. Submitted.
  191. Perna, N. T., G. F. Mayhew, G. Pósfai, S. Elliott, M. S. Donnenberg, J. B. Kaper, and F. R. Blattner. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infection and Immunity. 1998 66:3810-3817.
  192. Neves, B. C., S. Knutton, L. R. Trabulsi, V. Sperandio, J. B. Kaper, G. Dougan, and G. Frankel. Molecular and ultrastructural characterization of EspA from different enteropathogenic Escherichia coli serotypes. FEMS Microbiology Letters. 1998, 169:73-80.
  193. Wieler, L. H., A. Schwanitz, E. Vieler, B. Busse, H. Steinrück, J. B. Kaper, and G. Baljer. Virulence properties of Shiga toxin-producing Escherichia coli (STEC) strains of serogroup O118, a major group of STEC pathogens in calves. Journal of Clinical Microbiology 1998 36:1604-1607.
  194. Collington, G. K., I. W. Booth, M. S. Donnenberg, J. B. Kaper, and S. Knutton. Enteropathogenic Escherichia coli virulence genes encoding secreted signalling proteins are essential for modulation of Caco-2 cell electrolyte transport. Infection and Immunity. 1998, 66:6049-6053.
  195. Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Molecular Microbiology. 1998, 30:911-921.
  196. Trucksis, M., J. Michalski, Y. Kang-Deng, and J. B. Kaper. The Vibrio cholerae genome contains two unique circular chromosomes. Proceedings of the National Academy of Sciences, USA. 1998, 95:14464-14469.
  197. Karaolis, D. K. R., S. Somara, D. R. Maneval, Jr., J. A. Johnson, and J. B. Kaper. A bacteriophage encoding a pathogenicity island, type IV pilus, and phage receptor in epidemic Vibrio cholerae. Nature. 1999, 399:375-379.
  198. Mellies, J., S. J. Elliott, V. Sperandio, M. S. Donnenberg, and J. B. Kaper. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE) - encoded regulator (Ler). Molecular Microbiology. 1999, 33:296-306.